Time In the Market on MSN

AbbVie’s Power Play: How Skyrizi, Rinvoq, and a Surging Brain Business Are Crushing It (Even if Botox Isn't)

AbbVie's Q3 2025 earnings are in. Skyrizi is on fire, neuroscience is booming, but Botox is a bust. Get the summary.

The Saints: 'People were weeping – not because we were playing badly'

A quarter of a century has passed since Clare Teal, the jazz singer from Kildwick in North Yorkshire, first came to national ...